Nanoparticles in cancer therapy and diagnosis (Q34804817)

4 August 2017

1 reference

title

Nanoparticles in cancer therapy and diagnosis (English)

1 reference

4 August 2017

0 references

0 references

3

0 references

Irène Brigger

series ordinal

1

object named as

Irène Brigger

1 reference

4 August 2017

2

Catherine Dubernet

1 reference

PubMed ID

12204596

4 August 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

Advanced Drug Delivery Reviews

4 August 2017

1 reference

4 August 2017

54

1 reference

4 August 2017

631-651

1 reference

4 August 2017

5

1 reference

Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Control of tumour vascular permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Direct measurement of the extravasation of polyethyleneglycol-coated liposomes into solid tumor tissue by in vivo fluorescence microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Transvascular drug delivery in solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Actinomycin D adsorbed on polymethylcyanoacrylate nanoparticles: Increased efficiency against an experimental tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Tissue distribution of antitumor drugs associated with polyalkylcyanoacrylate nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Doxorubicin-loaded nanoparticles: increased efficiency in murine hepatic metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Investigation of the role of macrophages on the cytotoxicity of doxorubicin and doxorubicin-loaded nanoparticles on M5076 cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Liposomal doxorubicin-induced toxicity: depletion and impairment of phagocytic activity of liver macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Increased bone marrow toxicity of doxorubicin bound to nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Acute renal toxicity of doxorubicin (adriamycin)-loaded cyanoacrylate nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Toxicity of polyalkylcyanoacrylate nanoparticles II: Doxorubicin-loaded nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Diminished genotoxicity of mitomycin C and farmorubicin included in polybutylcyanoacrylate nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Biodegradable long-circulating polymeric nanospheres

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Nanoparticulate systems for brain delivery of drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Influence of surface-modifying surfactants on the pharmacokinetic behavior of 14C-poly (methylmethacrylate) nanoparticles in experimental tumor models.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Development of sterically stabilized poly(isobutyl 2-cyanoacrylate) nanoparticles by chemical coupling of poly(ethylene glycol).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Photodynamic therapy of tumours with hexadecafluoro zinc phthalocynine formulated in PEG-coated poly(lactic acid) nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Lymphatic targeting with nanoparticulate system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Selective drug delivery to peri-tumoral region and regional lymphatics by local injection of aclarubicin adsorbed on activated carbon particles in patients with breast cancer--a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Gadolinium neutron-capture therapy using novel gadopentetic acid-chitosan complex nanoparticles: in vivo growth suppression of experimental melanoma solid tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Spongelike alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Adsorption of oligonucleotides onto polyisohexylcyanoacrylate nanoparticles protects them against nucleases and increases their cellular uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Antisense effects of cholesterol-oligodeoxynucleotide conjugates associated with poly(alkylcyanoacrylate) nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Highly efficient cellular uptake of c-myb antisense oligonucleotides through specifically designed polymeric nanospheres.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Antisense oligonucleotide delivery with polyhexylcyanoacrylate nanoparticles as carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

EWS fli-1 antisense nanocapsules inhibits ewing sarcoma-related tumor in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Resistance mechanisms associated with altered intracellular distribution of anticancer agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant tumour cells in culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

On the mechanism of action of doxorubicin encapsulation in nanospheres for the reversal of multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Uptake of doxorubicin from loaded nanoparticles in multidrug-resistant leukemic murine cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

On the use of ion-pair chromatography to elucidate doxorubicin release mechanism from polyalkylcyanoacrylate nanoparticles at the cellular level

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Synthesis and antiproliferative effects of a 4'-morpholino-9-methyl anthracycline

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier system.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Increased cytotoxicity of nanoparticle-carried Adriamycin in vitro and potentiation by verapamil and amiodarone.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

In vitro model for the degradation of alkylcyanoacrylate nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Design of folic acid-conjugated nanoparticles for drug targeting

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Green- and red-fluorescent nanospheres for the detection of cell surface receptors by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Time-resolved fluorescence imaging for quantitative histochemistry using lanthanide chelates in nanoparticles and conjugated to monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Development of novel dye-doped silica nanoparticles for biomarker application

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Labelled polycyanoacrylate nanoparticles for human in vivo use

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Indirect computed tomography lymphography using iodinated nanoparticles to detect cancerous lymph nodes in a cutaneous melanoma model

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Characterization of normal and cancerous lymph nodes on indirect computed tomography lymphographic studies after interstitial injection of iodinated nanoparticles.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

MR imaging of phagocytosis in experimental gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

MR lymphography: study of a high-efficiency lymphotrophic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Improvement of MRI probes to allow efficient detection of gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

Antibody-magnetite nanoparticles: in vitro characterization of a potential tumor-specific contrast agent for magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-alpha carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900044-3

7 January 2021

10.1016/S0169-409X(02)00044-3

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12204596